Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $107 |
| Triangulated Fair Value | $115 |
| 12-mo Scenario PWEV | $115 |
| Implied Return | +8% |
| Forward P/E | 13.9x |
| Market Cap | $21B |
| 52-Week Range | $70 – $135 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $233, +118% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($107) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Crush / Protein Margin Reset' (22%) — targets $40, -62% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 65% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.23 vs analyst floor +0.08 → delta +0.15 (n=23 mgmt / 14 Q&A; 6th pctile across the S&P book, z -1.5).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.23 | +0.08 | +0.15 |
| 2025Q4 | +0.45 | +0.26 | +0.20 |
| 2025Q3 | +0.48 | +0.21 | +0.27 |
| 2025Q2 | +0.53 | +0.21 | +0.32 |
News (last 365d, 1000 articles): avg ticker sentiment +0.19 (bullish 27% / bearish 4%)
Scenario Analysis
The tree runs from a structural 'Structural — Crush / Protein Margin Reset' downside ($40) to a 'Spike — Supply Dislocation' bull case ($233); the probability-weighted blend (PWEV $115) is +8% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $40 | -62% |
| Cyclical Margin Trough | 18% | $72 | -33% |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $117 | +10% |
| Upcycle — Tight Margins | 20% | $186 | +75% |
| Spike — Supply Dislocation | 8% | $233 | +118% |
| Probability-Weighted (PWEV) | — | $115 | +8% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Crush / Protein Margin Reset (22%, $40). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 40.44; probability: 0.22.
- Cyclical Margin Trough (18%, $72). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising. Drivers — implied_target: 72.0; probability: 0.18.
- Base — Mid-Cycle Crush / Protein Margins (32%, $117). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns. Drivers — implied_target: 116.88; probability: 0.32.
- Upcycle — Tight Margins (20%, $186). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 186.43; probability: 0.2.
- Spike — Supply Dislocation (8%, $233). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins. Drivers — implied_target: 233.18; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $103 | -3% |
| Peer P/E re-rate | multiple | $132 | +24% |
| Peer EV/Revenue re-rate | multiple | $351 | +229% |
| Scenario PWEV | multiple | $115 | +8% |
| DCF (5-year + terminal) | cash flow + terminal × | $15 | -86% |
| Triangulated (weighted) | — | $115 | +8% |
DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $103 and 48% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (65% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 13x terminal FCF multiple → $15. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 17.235x) implies $132. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Agricultural Products & Protein | $80.5B | 100% | 2% | 0% | 15x | 6% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | ag-processing crush margins / protein cycle + commodity & feed costs |
| net_debt_or_cash_b | -15.45 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.06 |
| div_yield | 0.0259 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | crush / protein margin reset |
| upside | tight crush / protein margins |
Industry Context — Consumer Staples — Ag
This name sits in the Consumer Staples — Ag as a ag_products. ag-processing crush margins / protein cycle + commodity & feed costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: ADM (ag_products) · BG (ag_products) · TSN (ag_products)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Crush / Protein Margin Reset | 40% | 40% | |
| Mid-Cycle — Normalised Margins | 32% | 32% | |
| Tight-Margin Upcycle | 28% | 28% |
On the cluster's key downside — Crush / Protein Margin Reset () — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $82B | $2B | $5B | $5B | $1B | $1B |
| FY+2 | $84B | $2B | $5B | $5B | $1B | $1B |
| FY+3 | $85B | $2B | $5B | $5B | $1B | $1B |
| FY+4 | $85B | $2B | $5B | $5B | $1B | $1B |
| FY+5 | $86B | $2B | $5B | $5B | $1B | $1B |
| Terminal | — | — | — | — | $1B × 13x | $13B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $6B + PV(terminal) $13B = EV $18B; + net cash → equity $3B ÷ diluted shares 0.19B = $15/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $28/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 1% vs WACC 9% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| ADM | 0.582x | 16.61x | 2% | 1% |
| TSN | 0.501x | 12.92x | 2% | 4% |
| DLTR | 1.495x | 17.86x | 5% | 9% |
| CHD | 4.022x | 26.04x | 4% | 20% |
| Median | 1.0385x | 17.235x | — | — |
Peer-median fwd P/E → $132; EV/Rev → $351.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| Scenario PWEV | $115 | 50% | $58 |
| Monte Carlo median | $103 | 30% | $31 |
| Peer P/E | $132 | 20% | $26 |
| Triangulated | — | 100% | $115 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 9.1x | 11.0x | 13.0x | 14.9x | 16.9x |
|---|---|---|---|---|---|
| 7% | $1 | $12 | $22 | $33 | $44 |
| 8% | $-2 | $8 | $18 | $28 | $39 |
| 9% | $-5 | $5 | $15 | $24 | $34 |
| 10% | $-8 | $1 | $11 | $20 | $29 |
| 11% | $-10 | $-2 | $7 | $16 | $25 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-92 | $-36 | $20 | $76 | $132 |
| -1.5pp | $-102 | $-42 | $18 | $77 | $137 |
| +0.0pp | $-113 | $-49 | $15 | $78 | $142 |
| +1.5pp | $-125 | $-57 | $11 | $79 | $147 |
| +3.0pp | $-138 | $-65 | $7 | $79 | $152 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $-113 | $142 | $255 |
| Terminal × ±15% | $5 | $24 | $19 |
| Revenue CAGR ±3pp | $20 | $7 | $13 |
| WACC ±1pp | $11 | $18 | $7 |
| FCF conversion ±10% | $15 | $15 | $0 |
Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 15x)
| Multiple | 10.5x | 12.8x | 15.0x | 17.2x | 19.5x |
|---|---|---|---|---|---|
| SoP/share | $4,277 | $5,232 | $6,145 | $7,057 | $8,012 |
Load-Bearing Assumptions
DCF: WACC 9%, terminal multiple 13×, FY+5 revenue $86B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
DCF $15 vs MC median $103 diverge by 86%. Investigate which assumptions differ. A miss on Gross Margin drops the case toward the structural target $40.
Fact / Inference / Speculation
- FACT: Spot $107; 52-week range $70–$135; engine rating HOLD; base-case target $115 (+8%).
- INFERENCE: Triangulated FV $115 (+8%). Gross Margin explains 65% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 65% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $74 (-31% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (65% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).